Statement from Binita Ashar, M.D., of the FDA ’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants
Statement from Binita Ashar, M.D., of the FDA ’s Center for Devices and Radiological Health on agency’s continuing efforts to educate patients on known risk of lymphoma from breast implants
Source: Food and Drug Administration - Category: American Health Source Type: news
More News: American Health | Breast Augmentation | Education | Food and Drug Administration (FDA) | Lymphoma | Plastic Surgery